NEW YORK--(BUSINESS WIRE)--HMS Holdings Corp. (NASDAQ: HMSY) today announced its financial results for the third quarter of 2011.
For the quarter ended September 30, 2011, revenue increased 15.4% to $92.4 million, compared to $80.0 million for the same period a year ago. Net income for the quarter was $14.4 million or $0.17 per diluted common share compared to net income of $11.0 million or $0.13 per diluted common share for the same period a year ago, an increase of 30.7%.
For the nine months ended September 30, 2011, revenue increased 22.5% to $264.2 million, compared to $215.7 million for the same period a year ago. Net income for the nine months ended September 30, 2011 was $36.7 million or $0.42 per diluted common share, compared to net income of $27.7 million or $0.33 per diluted common share for the same period a year ago, an increase of 27.2%.
2011 Revised Guidance & 2012 Guidance
As a result of the delay in the issuance of the Medicaid RAC (Recovery Audit Contractor) final rule, states’ progress in procuring, awarding and implementing RAC contracts was slower than anticipated and accordingly, the Company is revising revenue guidance for 2011 from $372.0 million to $363.0 million (+19.8% y/y). However, improved operational performance permits the Company to raise projected GAAP earnings per share (EPS) from $0.59 to $0.60 (+27.7% y/y) on a fully diluted basis.
The Company also announced initial guidance for 2012. Revenue is projected to grow to $435.0 million (+19.8% over revised 2011 guidance), fully diluted GAAP EPS is projected to increase to $0.74 (+23.3% over 2011 revised guidance).
“On the sales front, HMS continued to win competitive Medicaid RAC procurements in the third quarter,” said Lucia. “We are very pleased that the components of CMS’s Final Rule, which governs Medicaid RAC implementations and provides guidance to states, aligns favorably with HMS’s capabilities, even though the delay in the rule slowed a number of state contract awards and implementations. With contract award activity resuming as states re-focus on Medicaid RAC, we’re confident that the opportunity associated with this program will be realized in 2012 and beyond.”
Q3 2011 Conference Call
HMS will be hosting its third quarter 2011 conference call and webcast with the investment community on Friday, October 28, 2011 at 9:00 am Eastern Time. Individuals can access the webcast at http://investor.hms.com or listen to the call at 1-877-591-4959. International participants can listen to the call at 719-325-4791.
The webcast will be archived on the website. Individuals can listen to the replay at 1-888-203-1112. International participants can listen to the replay at 1-719-457-0820. The conference ID is 1811594. The replay will be available at 11 a.m. ET on October 28 through 11:59 p.m. ET on November 4, 2011.
The HMS Form 10-Q for the quarter September 30, 2011 will be filed and available on our website on http://investor.hms.com or about November 9, 2011, and will contain additional information about our results of operations for the fiscal year-to-date. This press release and the interim financial statements herein will be available at http://investor.hms.com for at least a 12-month period. Shareholders and interested investors are welcome to contact Investor Relations at 212-857-5986.
About HMS Holdings
HMS Holdings Corp. (NASDAQ: HMSY), is the nation's leader in coordination of benefits and program integrity services for healthcare payors. HMS's clients include health and human services programs in more than 40 states; commercial programs, including commercial plans, employers, and over 120 Medicaid managed care plans; the Centers for Medicare and Medicaid Services (CMS); and Veterans Administration facilities. As a result of the company’s services, clients recovered over $1.8 billion in 2010, and saved billions of dollars more through prevention of erroneous payments.
Use of Non-GAAP Financials
This press release includes presentations of earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA. Adjusted EBITDA represents EBITDA adjusted for stock-based compensation expense. EBITDA is a measure commonly used by the capital markets to value enterprises. EBITDA is a non-GAAP financial measure and is reconciled to income before income taxes, which the Company's management believes to be the most comparable generally accepted accounting principles ("GAAP") measure. Adjusted EBITDA results are calculated by adjusting GAAP income before income taxes to exclude the effects of depreciation, amortization of intangible assets, stock-based compensation expense, and net interest expense.
This press release also includes presentations of adjusted EPS. Adjusted EPS represents EPS adjusted for stock-based compensation expense and amortization of intangibles. Adjusted EPS is a non-GAAP financial measure and is reconciled to EPS, which the Company’s management believes to be the most comparable GAAP measure.
The press release containing the reconciliation to GAAP measures is available on the Investor Section of our website.
The Company uses these non-GAAP financial measures for internal management purposes, when publicly providing guidance on possible future results, and as a means to evaluate period-to-period comparisons. The Company's management believes that these non-GAAP financial measures are a common measure used by investors and analysts to evaluate its performance. These non-GAAP financial measure are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, income before income taxes in accordance with GAAP.
Safe Harbor Statement
This Press Release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements give our expectations or forecasts of future events; they do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “anticipates,” “estimates,” “expects,” “projects,” “intends,” “plans,” “believes,” “will,” “target,” “seeks,” “forecast” and similar expressions. In particular, these include statements relating to future actions, business plans, objects and prospects, and future operating or financial performance. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. We caution you therefore against relying on any of these forward-looking statements.
Factors that could cause or contribute to such differences include, but are not limited to: the development by competitors of new or superior services or products or the entry into the market of new competitors; all the risks inherent in the development, introduction, and implementation of new products and services; the loss of a major customer, customer dissatisfaction or early termination of customer contracts triggering significant costs or liabilities; variations in our results of operations; negative results of government reviews, audits or investigations to verify our compliance with contracts and applicable laws and regulations; changing conditions in the healthcare industry which could simplify the reimbursement process and reduce the need for and price of our services; government regulatory, political and budgetary pressures that could affect the procurement practices and operations of healthcare organizations, reducing the demand for our services; our failure to comply with laws and regulations governing health data or to protect such data from theft and misuse. A further description of risks, uncertainties, and other matters can be found in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, a copy of which may be obtained from the Company’s website at www.hms.com under the “Investor Relations” tab. Any forward-looking statements made by us in this Press Release speak only as of the date of this Press Release. Factors or events that could cause actual results to differ may emerge from time to time and it is not possible for us to predict all of them. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
HMS HOLDINGS CORP. AND SUBSIDIARIES | ||||||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||
For the Three and Nine-Months Ended September 30, 2011 and 2010 | ||||||||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||||||||
(unaudited) |
||||||||||||||||||||
Three months ended Sept 30, |
Nine months ended Sept 30, |
|||||||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||||||
Revenue | $ | 92,356 | $ | 80,022 | $ | 264,159 | $ | 215,700 | ||||||||||||
Cost of services: | ||||||||||||||||||||
Compensation | 31,762 | 27,211 | 94,604 | 76,391 | ||||||||||||||||
Data processing | 5,973 | 4,576 | 16,607 | 12,691 | ||||||||||||||||
Occupancy | 3,794 | 3,490 | 11,328 | 9,640 | ||||||||||||||||
Direct project costs | 9,893 | 9,818 | 30,546 | 25,596 | ||||||||||||||||
Other operating costs | 4,637 | 4,565 | 13,448 | 11,738 | ||||||||||||||||
Amortization of acquisition related software | ||||||||||||||||||||
and intangibles | 1,660 | 1,665 | 5,048 | 4,566 | ||||||||||||||||
Total cost of services | 57,719 | 51,325 | 171,581 | 140,622 | ||||||||||||||||
Selling, general & administrative expenses | 10,560 | 10,419 | 31,932 | 28,899 | ||||||||||||||||
Total operating expenses | 68,279 | 61,744 | 203,513 | 169,521 | ||||||||||||||||
Operating income | 24,077 | 18,278 | 60,646 | 46,179 | ||||||||||||||||
Interest expense | (19 | ) | (24 | ) | (65 | ) | (70 | ) | ||||||||||||
Other income/(expense) | 165 | (31 | ) | 714 | (31 | ) | ||||||||||||||
Interest income | 14 | 32 | 50 | 73 | ||||||||||||||||
Income before income taxes | 24,237 | 18,255 | 61,345 | 46,151 | ||||||||||||||||
Income taxes | 9,822 | 7,209 | 24,691 | 18,414 | ||||||||||||||||
Net income | $ | 14,415 | $ | 11,046 | $ | 36,654 | $ | 27,737 | ||||||||||||
Basic income per common share data: | ||||||||||||||||||||
Net income per basic share | $ | 0.17 | $ | 0.13 | $ | 0.43 | $ | 0.34 | ||||||||||||
Weighted average common shares outstanding, basic | 84,159 | 82,009 | 84,372 | 81,367 | ||||||||||||||||
Diluted income per share data: | ||||||||||||||||||||
Net income per diluted share | $ | 0.17 | $ | 0.13 | $ | 0.42 | $ | 0.33 | ||||||||||||
Weighted average common shares, diluted | 86,869 | 85,450 | 87,233 | 85,040 | ||||||||||||||||
HMS HOLDINGS CORP. AND SUBSIDIARIES |
||||||||
September 30, |
December 31, 2010 |
|||||||
Assets |
||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 140,451 | $ | 94,836 | ||||
Accounts receivable, net of allowance of $650 at September 30, 2011 | ||||||||
and $799 at December 31, 2010 |
83,483 | 75,123 | ||||||
Prepaid expenses and other current assets | 12,563 | 10,089 | ||||||
Total current assets | 236,497 | 180,048 | ||||||
Property and equipment, net | 46,561 | 44,713 | ||||||
Goodwill, net | 107,026 | 107,414 | ||||||
Intangible assets, net | 16,136 | 19,826 | ||||||
Other assets | 847 | 904 | ||||||
Accounts receivable, long term | 2,160 | - | ||||||
Total assets | $ | 409,227 | $ | 352,905 | ||||
Liabilities and Shareholders' Equity |
||||||||
Current liabilities: | ||||||||
Accounts payable, accrued expenses and other liabilities | $ | 28,421 | $ | 32,502 | ||||
Contingent payables | 3,315 | - | ||||||
Total current liabilities | 31,736 | 32,502 | ||||||
Long-term liabilities: | ||||||||
Contingent payables | - | 2,573 | ||||||
Accrued deferred rent | 1,419 | 1,842 | ||||||
Other liabilities | 2,221 | 2,582 | ||||||
Deferred tax liabilities | 7,408 | 5,768 | ||||||
Total long-term liabilities | 11,048 | 12,765 | ||||||
Total liabilities | 42,784 | 45,267 | ||||||
Shareholders' equity: | ||||||||
Preferred stock - $.01 par value; 5,000,000 shares authorized; none issued | - | - | ||||||
Common stock - $.01 par value; 125,000,000 shares authorized; | ||||||||
89,961,818 shares issued and 84,973,280 shares outstanding at September 30, 2011; | ||||||||
88,341,546 shares issued and 83,353,008 shares outstanding at December 31, 2010 | 900 | 883 | ||||||
Capital in excess of par value | 226,584 | 204,450 | ||||||
Retained earnings | 148,356 | 111,702 | ||||||
Treasury stock, at cost; 4,988,538 shares at September 30, 2011 | ||||||||
and December 31, 2010 | (9,397 | ) | (9,397 | ) | ||||
Total shareholders' equity | 366,443 | 307,638 | ||||||
Total liabilities and shareholders' equity | $ | 409,227 | $ | 352,905 | ||||
HMS HOLDINGS CORP. AND SUBSIDIARIES | ||||||||||||||
Consolidated Statements of Cash Flows | ||||||||||||||
For the Nine Months Ended September 30, 2011 and 2010 | ||||||||||||||
(in thousands) |
||||||||||||||
(unaudited) |
||||||||||||||
|
Nine months ended September 30, |
|||||||||||||
2011 |
2010 | |||||||||||||
Operating activities: | ||||||||||||||
Net income | $ | 36,654 | $ | 27,737 | ||||||||||
Adjustments to reconcile net income to net cash provided by | ||||||||||||||
operating activities: | ||||||||||||||
Depreciation and amortization | 14,930 | 11,478 | ||||||||||||
Stock-based compensation expense | 5,884 | 5,334 | ||||||||||||
Deferred income taxes | 1,508 | 546 | ||||||||||||
Decrease in allowance for doubtful accounts | (149 | ) | 464 | |||||||||||
Change in fair value of contingent consideration | 391 | - | ||||||||||||
Loss on disposal of fixed assets | 5 | 22 | ||||||||||||
Changes in assets and liabilities: | ||||||||||||||
(Increase)/Decrease in accounts receivable | (10,371 | ) | (10,020 | ) | ||||||||||
(Increase)/Decrease in prepaid expenses, prepaid income taxes | ||||||||||||||
and other current assets | 2,306 | (1,138 | ) | |||||||||||
(Increase)/Decrease in other assets | 57 | 685 | ||||||||||||
(Decrease)/Increase in accounts payable, accrued expenses | ||||||||||||||
and other liabilities | (2,125 | ) | (43 | ) | ||||||||||
Net cash provided by operating activities | 49,090 | 35,065 | ||||||||||||
Investing activities: | ||||||||||||||
Investment in certificate of deposit | (4,809 | ) | - | |||||||||||
Purchases of property and equipment | (13,092 | ) | (10,488 | ) | ||||||||||
Purchase of building and land | - | (9,886 | ) | |||||||||||
Acquisition of AMG-SIU | 161 | (12,795 | ) | |||||||||||
Acquisition of Verify Solutions | (500 | ) | - | |||||||||||
Acquisition of Chapman Kelly | - | (13,001 | ) | |||||||||||
Investment in capitalized software | (1,502 | ) | (1,512 | ) | ||||||||||
Net cash used in investing activities | (19,742 | ) | (47,682 | ) | ||||||||||
Financing activities: | ||||||||||||||
Proceeds from exercise of stock options | 9,013 | 5,486 | ||||||||||||
Payments of tax withholdings on behalf of employees for | (903 | ) | - | |||||||||||
net-share settlement for stock-based compensation | ||||||||||||||
Excess tax benefit from exercised stock options | 8,157 | 8,303 | ||||||||||||
Net cash provided by financing activities | 16,267 | 13,789 | ||||||||||||
Net increase in cash and cash equivalents | 45,615 | 1,172 | ||||||||||||
Cash and cash equivalents at beginning of period | 94,836 | 64,863 | ||||||||||||
Cash and cash equivalents at end of period | $ | 140,451 | $ | 66,035 | ||||||||||
Supplemental disclosure of cash flow information: | ||||||||||||||
Cash paid for income taxes | $ | 11,547 | $ | 11,269 | ||||||||||
Cash paid for interest | $ | 89 | $ | 46 | ||||||||||
Supplemental disclosure of noncash investing activities: | ||||||||||||||
Accrued property and equipment purchases | $ | 438 | $ | 674 | ||||||||||
Accrued acquisition related contingent consideration | $ | 351 | $ | 2,573 | ||||||||||
HMS HOLDINGS CORP. AND SUBSIDIARIES (In thousands, except share and per share amounts) (unaudited) |
||||||||||||||||
Reconciliation of net income to EBITDA and adjusted EBITDA |
Three Months Ended |
Nine months Ended |
||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Net Income | $ |
14,415 |
|
$ | 11,046 | $ |
36,654 |
|
$ | 27,737 | ||||||
Net interest (income)/expense | 5 | (8 | ) | 15 | (3 | ) | ||||||||||
Income taxes | 9,822 | 7,209 | 24,691 | 18,414 | ||||||||||||
Depreciation and amortization, net of deferred | ||||||||||||||||
financing costs included in net interest expense | 5,125 | 4,171 | 14,930 | 11,478 | ||||||||||||
Earnings before interest, taxes, depreciation | ||||||||||||||||
and amortization (EBITDA) | 29,367 | 22,418 | 76,290 | 57,626 | ||||||||||||
Share-based compensation expense | 1,918 | 1,906 | 5,884 | 5,334 | ||||||||||||
Adjusted EBITDA | $ | 31,285 | $ | 24,324 | $ | 82,174 | $ | 62,960 | ||||||||
Reconciliation of net income to GAAP EPS and |
For the Year Ended |
|||||||||||||||
2011 | 2012 | |||||||||||||||
Net Income | $ | 52,100 | $ | 65,600 | ||||||||||||
Stock option expense | 4,905 | 5,956 | ||||||||||||||
Amortization of intangibles | 3,964 | 3,959 | ||||||||||||||
Subtotal | $ | 60,969 | $ | 75,515 | ||||||||||||
Weighted average common shares, diluted | 86,916 | 88,700 | ||||||||||||||
Diluted GAAP EPS | $ | 0.60 | $ | 0.74 | ||||||||||||
Diluted adjusted EPS | $ | 0.70 | $ | 0.85 |